Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-25 @ 3:15 PM
NCT ID:
NCT00772668
Group ID:
EG000
Title:
RCVELP
Description:
Rituximab, Cyclophosphamide, Bortezomib, Prednisone (RCVELP):
* Rituximab
* Induction: 375 mg/m2 IV infusion on Day 1 of every 21 days cycle for 8 cycles
* Maintenance: 375/m2 Days 1, 8, 15, 22 every 6 months for up to 4 cycles
* Cyclophosphamide: 750 mg/m2 intravenous piggyback (IVPB) on Day 1 of every 21 day cycle for 8 cycles
* Bortezomib: 1.6 mg/m2 IV push on Days 1 and 8 of every 21 days cycle for 8 cycles
* Prednisone: 100 mg PO daily on Days 1-5 of every 21 day cycle for 8 cycles
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
3
Other Number Affected:
0
Other Number At Risk:
3
Study:
NCT00772668
Results Section:
NCT00772668
Adverse Events Module:
NCT00772668